Twitter Summary: FDA approves Trulicity for #T2D, 1 st ready-to-use once-weekly GLP-1 agonist in the US, with a patient-friendly “auto-injector” – launch for later this...
Diabetes Drug News
Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.
Metformin Insulin SGLT-2 GLP-1 DPP-4 Combo drugs Sulfonylureas TZDs
38 readers recommended
41 readers recommended
On June 17, Boehringer Ingelheim (BI) and Lilly announced the resubmission to the FDA of the SGLT-2 inhibitor Jardiance (empagliflozin) for the treatment of type 2...
40 readers recommended
Twitter summary: FDA grants “tentative approval” to Lilly/BI’s Basaglar – new insulin option will be an alternative to Lantus in future On August 18, Eli Lilly and...
39 readers recommended
Twitter Summary: @LillyPad receives EU approval for Humalog 200 units/ml Kwikpen – 600 units of insulin in a 3 ml pen, hopeful US resubmission late 2014 Eli Lilly...
39 readers recommended
Debates in type 1 diabetes – what is the future of technology and what is a “cure"? Part three of our interview with David Panzirer and Dana Ball.
41 readers recommended
Twitter summary: New Sanofi & MannKind partnership to bring inhaled insulin Afrezza to US in early 2015, presumably primarily to type 2 patients to start On August...
33 readers recommended
Twitter summary: Roche’s Lucentis granted “priority review” from FDA – decision by Feb. 2015, potentially 1 st ever eye medicine for diabetic retinopathy Roche recently...
44 readers recommended
Advances in type 1 diabetes at The American Diabetes Association 74th Scientific Sessions
37 readers recommended
Twitter summary: FDA approves first-ever SGLT-2 inhibitor/metformin combo pill in the US – Janssens’s Invokamet launched Aug 18 On August 8, Janssen announced the FDA...
43 readers recommended
Twitter summary: Contrave launched in the US w/ weight support program + savings/loyalty programs offer new option for patients Two healthcare companies, Orexigen and...
53 readers recommended
On June 19, Novo Nordisk announced the launch of its FlexTouch pen for the long-acting basal insulin Levemir (insulin detemir). FlexTouch, which has been approved in...
38 readers recommended
Twitter summary: Exciting positive vote for #liraglutide #emdac on possible new therapy for #obesity! Plus, our favorite open public hearing yet. Yesterday on September...
50 readers recommended
Twitter summary: FDA approves Xigduo XR – first once-daily SGLT-2 inhibitor/metformin fixed dose combo in the US AstraZeneca recently announced that the FDA approved...
37 readers recommended
We’ve been following the development of Lilly’s Trulicity (dulaglutide), a once-weekly GLP-1 receptor agonist , for almost two years now, so it was encouraging to hear...
30 readers recommended
Twitter summary: FDA approves Contrave weight management drug, with potential future use in #T2D On September 10, the FDA announced the approval of Orexigen’s weight...
31 readers recommended
Expert Dr. Irl Hirsch’s eight tips for managing diabetes on a budget.
30 readers recommended
Twitter summary: BI/Lilly launch Jardiance in the US, making it the 3 rd SGLT-2 inhibitor on the market; savings program for one-year free supply After its recent FDA...
48 readers recommended
The Future of Type 1 Diabetes – what challenges and promises lie ahead? Part two of our interview with David Panzirer and Dana Ball.
49 readers recommended
Twitter summary: @LillyDiabetes launches Trulicity in the US – first ready-to-use once-weekly GLP-1, available w/savings program for commercially insured On November 10...
38 readers recommended
Can a type 2 diabetes drug work for type 1? Will an experimental drug improve blood glucose and body weight?